Fresenius Medical Care AG (NYSE:FMS) Shares Sold by Fiduciary Management Inc. WI

Fiduciary Management Inc. WI decreased its position in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,308,663 shares of the company's stock after selling 252,521 shares during the period. Fiduciary Management Inc. WI owned about 1.08% of Fresenius Medical Care worth $142,828,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Moran Wealth Management LLC lifted its position in shares of Fresenius Medical Care by 9.1% during the fourth quarter. Moran Wealth Management LLC now owns 254,710 shares of the company's stock worth $5,767,000 after purchasing an additional 21,334 shares in the last quarter. ABC Arbitrage SA purchased a new stake in Fresenius Medical Care during the 4th quarter worth approximately $4,215,000. OLD Mission Capital LLC acquired a new stake in Fresenius Medical Care during the 4th quarter worth approximately $3,545,000. Broyhill Asset Management purchased a new position in Fresenius Medical Care in the 4th quarter valued at approximately $3,412,000. Finally, Marshall Wace LLP boosted its position in Fresenius Medical Care by 128.0% in the 4th quarter. Marshall Wace LLP now owns 129,581 shares of the company's stock valued at $2,934,000 after buying an additional 72,740 shares during the period. 8.37% of the stock is currently owned by hedge funds and other institutional investors.

Fresenius Medical Care Stock Performance

Shares of FMS traded up $0.47 during midday trading on Tuesday, reaching $23.99. 983,950 shares of the stock were exchanged, compared to its average volume of 319,917. The company has a market capitalization of $14.08 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 0.76 and a beta of 0.93. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. Fresenius Medical Care AG has a twelve month low of $17.93 and a twelve month high of $25.96. The business's 50-day moving average price is $23.92 and its 200 day moving average price is $22.92.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on FMS shares. StockNews.com raised Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 5th. Truist Financial upped their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the stock a "hold" rating in a research report on Monday, January 6th.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.